BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17467142)

  • 1. Prevention and treatment of uterine bleeding in hematologic malignancy.
    Quaas AM; Ginsburg ES
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):3-8. PubMed ID: 17467142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.
    Chiusolo P; Salutari P; Sica S; Scirpa P; Laurenti L; Piccirillo N; Leone G
    Bone Marrow Transplant; 1998 Apr; 21(8):821-3. PubMed ID: 9603407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uterine bleeding in the adolescent hematology/oncology patient.
    Shackelford DP; Adcock W
    Pediatr Hematol Oncol; 1998; 15(3):287-9. PubMed ID: 9615330
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual suppression in special circumstances.
    Kirkham YA; Ornstein MP; Aggarwal A; McQuillan S;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):915-924. PubMed ID: 25375306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine polypectomy in the management of abnormal uterine bleeding: A systematic review.
    Nathani F; Clark TJ
    J Minim Invasive Gynecol; 2006; 13(4):260-8. PubMed ID: 16825064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anomalous uterine bleeding in the perimenopause: fibromatosis, hyperplastic endometriopathy and GnRH analogs].
    Vitale G; Linciano M; Salamanca S; Ferrari P
    Minerva Ginecol; 1994 Jun; 46(6):317-20. PubMed ID: 7936383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhagic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):408-15. PubMed ID: 17525898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
    Bates JS; Buie LW; Woodis CB
    Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding.
    Clark TJ; Middleton LJ; Cooper NA; Diwakar L; Denny E; Smith P; Gennard L; Stobert L; Roberts TE; Cheed V; Bingham T; Jowett S; Brettell E; Connor M; Jones SE; Daniels JP
    Health Technol Assess; 2015 Jul; 19(61):1-194. PubMed ID: 26240949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of vaginal danazol vs diphereline (a synthetic GnRH agonist) in the control of bleeding during hysteroscopic myomectomy in women with abnormal uterine bleeding: a randomized controlled clinical trial.
    Sayyah-Melli M; Bidadi S; Taghavi S; Ouladsahebmadarek E; Jafari-Shobeiri M; Ghojazadeh M; Rahmani V
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():48-51. PubMed ID: 26675055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol; 2021 Jan; 137(1):e7-e15. PubMed ID: 33399429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal uterine bleeding: a management algorithm.
    Ely JW; Kennedy CM; Clark EC; Bowdler NC
    J Am Board Fam Med; 2006; 19(6):590-602. PubMed ID: 17090792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding.
    Kucuk M; Okman TK
    Fertil Steril; 2005 Jan; 83(1):189-94. PubMed ID: 15652906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.
    Sica S; Salutari P; Chiusolo P; Cicconi S; Sorá F; Laurenti L; Piccirillo N; Scirpa P; Leone G
    Blood; 1999 May; 93(9):3154. PubMed ID: 10336272
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on the effect of vaginal administration of micronized progesterone at dysfunctional uterine bleeding in premenopause].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2009; 48(2):3-7. PubMed ID: 20198768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to hysterectomy for the treatment of excessive uterine bleeding.
    Robins JC; Liu J
    Int J Clin Pract; 2000 May; 54(4):233-7. PubMed ID: 10912312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of cabergoline (Dostinex) on women with symptomatic myomatous uterus: a randomized trial.
    Vahdat M; Kashanian M; Ghaziani N; Sheikhansari N
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():74-78. PubMed ID: 27639604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.
    DeVore GR; Owens O; Kase N
    Obstet Gynecol; 1982 Mar; 59(3):285-91. PubMed ID: 6281704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.